Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.
about
DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic Syndrome.KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia.High bone marrow ID2 expression predicts poor chemotherapy response and prognosis in acute myeloid leukemia.Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia.Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia.Identification and validation of SRY-box containing gene family member SOX30 methylation as a prognostic and predictive biomarker in myeloid malignancies.Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia
P2860
Q42361215-E37D2B59-D391-4F38-A345-7EE42041CB20Q42371609-68DE5108-C86F-4BA4-AB7B-EFEB412BF56DQ47346339-03CE704E-124E-41A4-AAF2-8E28E1518A36Q47991823-50BC4E97-1704-41C2-81B1-74487C316877Q48105461-C1F29219-C136-4B9A-89AF-AF291AC0F06DQ48344943-76CE2602-ABB3-43C5-A3DE-70E4FBC0E7F3Q55279230-8D62C838-7203-4EFD-B452-F8C35E379CD8Q55312785-1540ECE0-80F8-415F-A2DC-25EC9F8A7225Q55651366-16005FB2-5067-4007-80AC-9AF00D2A9689Q59135325-9BA85512-E2BC-4C22-87EF-F60047E9D10A
P2860
Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Epigenetic dysregulation of ID ...... tcome in myeloid malignancies.
@en
type
label
Epigenetic dysregulation of ID ...... tcome in myeloid malignancies.
@en
prefLabel
Epigenetic dysregulation of ID ...... tcome in myeloid malignancies.
@en
P2093
P2860
P356
P1476
Epigenetic dysregulation of ID ...... tcome in myeloid malignancies.
@en
P2093
Ji-Chun Ma
Jing-Dong Zhou
Ting-Juan Zhang
Xiang-Mei Wen
P2860
P304
P356
10.1111/JCMM.13073
P577
2017-04-27T00:00:00Z